| 000 | 01817 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517113353.0 | ||
| 264 | 0 | _c20171207 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1573-2592 | ||
| 024 | 7 |
_a10.1007/s10875-016-0327-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuez, Daniel | |
| 245 | 0 | 0 |
_aEfficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America. _h[electronic resource] |
| 260 |
_bJournal of clinical immunology _c10 2016 |
||
| 300 |
_a700-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBacterial Infections _xetiology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xcomplications |
| 650 | 0 | 4 | _aInfusions, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aStein, Mark | |
| 700 | 1 | _aGupta, Sudhir | |
| 700 | 1 | _aHussain, Iftikhar | |
| 700 | 1 | _aMelamed, Isaac | |
| 700 | 1 | _aParis, Kenneth | |
| 700 | 1 | _aDarter, Amy | |
| 700 | 1 | _aBourgeois, Christelle | |
| 700 | 1 | _aFritsch, Sandor | |
| 700 | 1 | _aLeibl, Heinz | |
| 700 | 1 | _aMcCoy, Barbara | |
| 700 | 1 | _aGelmont, David | |
| 700 | 1 | _aYel, Leman | |
| 773 | 0 |
_tJournal of clinical immunology _gvol. 36 _gno. 7 _gp. 700-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-016-0327-9 _zAvailable from publisher's website |
| 999 |
_c26379175 _d26379175 |
||